Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Injection for Cervicogenic Dizziness
NCT07053176Phase 4Enrolling by invitation
- Sponsor
- Uniter Biopharma
- Start
- Aug 2025
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Lidocaine Hydrochloride Injection, without epinephrine in cervicogenic dizziness, sponsored by Uniter Biopharma. Started Aug 2025; status: enrolling by invitation.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
cervicogenic dizziness
Beyond the preview
Go deeper on NCT07053176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07053176.